A5081617416- Liver Disease Diagnosis and Treatment
- Thyroid Disorders and Treatments
- Human Health and Disease
- Adrenal Hormones and Disorders
- Growth Hormone and Insulin-like Growth Factors
- Ophthalmology and Eye Disorders
- Mental Health and Psychiatry
- Psychosomatic Disorders and Their Treatments
- Blood disorders and treatments
- Cardiovascular Health and Risk Factors
- Renal Diseases and Glomerulopathies
- Amyloidosis: Diagnosis, Treatment, Outcomes
- COVID-19 and Mental Health
- Biomarkers in Disease Mechanisms
- Health and Well-being Studies
- Psychology of Development and Education
- Adipokines, Inflammation, and Metabolic Diseases
- Skin Diseases and Diabetes
- Diet, Metabolism, and Disease
- Cancer, Lipids, and Metabolism
- Neurological Complications and Syndromes
- Pituitary Gland Disorders and Treatments
- Neurological and metabolic disorders
- Adipose Tissue and Metabolism
- Long-Term Effects of COVID-19
Nicolae Testemițanu State University of Medicine and Pharmacy
2022-2024
Carilion Clinic
2023
Virginia Tech
2023
Abstract Introduction Pituitary adenomas account for 10-15% of all intracranial neoplasms. Around 1/3 cases are cystic pituitary presented by non-staining tumors, usually being prolactinomas and rarely – somatotropinomas. Combined prolactin growth hormone-secreting uncommon clinical diagnosis can be deferred due to symptoms specific only one the excess secreted hormones. Clinical Case A 47-years-old woman was referred our clinic in November 2022, her complaint headaches occipital region that...
Introduction. Type 2 DM accounts for over 95% of all diabetes cases worldwide and represents an important independent cardio-metabolic risk factor. This is the first national study (Epidemiological widespread endocrine pathologies (diabetes, obesity) in Republic Moldova its management strategy) that analyzes prevalence type mellitus (DM), prediabetes, obesity, dyslipidemia adult population Moldova. Material methods. epidemiological cross-sectional with cluster random sampling. A face-to-face...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Dyslipidemias are among the most important modifiable risk factors associated with cardiovascular pathology. Materials and methods. The preliminary results of observational, cross-sectional study conducted from February 2020 to January 2023 presented. prevalence dyslipidemia lipid profile in a sample 728 participants rural urban environments were analyzed. Results: In group mean age 47.14 ± 12.65 years, it was observed that elevated LDL- cholesterol decreased HDL-cholesterol levels frequent...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
The increasing prevalence of endocrine-disrupting chemicals in our environment is a worrying situation for the global population health. In recent years, significant attention has been paid to endocrine disruptors, thus, European Society Endocrinology, together with urges increase awareness their influence on human body. aim study identify disruptors pregnancy, order prevent negative impact maternal-fetal environment. was carried out based detailed analysis and synthesis literature,...
Obesity is a chronic disease with extensive health consequences. Its prevalence constantly increasing, including among children and young people. In this study we assessed the cardiometabolic risk its correlation leptin/adiponectin ratio in obese women. We enrolled 72 apparently healthy women, comprising 36 normal weight (BMI ≤ 25 kg/m²) obesity ≥ 30 kg/m²). The mean age was 34.1±5.6 years. Clinical paraclinical parameters were studied: body mass index (BMI), waist hip circumference,...
Background: Hypothyroidism is one of the most common endocrine disorders.Most patients with hypothyroidism have autoimmune thyroiditis (Hashimoto's), characterized by elevated concentrations anti-thyroperoxidase (ATPO) antibodies.Both overt (OH) and subclinical (SH) been associated cardiovascular risk factors, including markers inflammation.Highsensitivity C-reactive protein (hs-CRP) a veridical marker systemic inflammation.Even minor increase in hs-CRP considered risk; therefore, evidence...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Abstract Introduction Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of disease (GD). It more common in women, but men have severe evolution disease. GO appears 25–70% patients with GD and can a 5% cases even lead to sight loss. In mild forms local treatment often sufficient alleviate eye symptoms. However, moderate-to-severe systemic glucocorticoids are used, combined or not immunosuppressive drugs. glucocorticoid-refractory cases, conventional biological drugs been among...
Abstract Introduction Diffuse toxic goitre is an autoimmune disorder with a marked prevalence in women. Thrombocytopenia may coexist diffuse goitre. Nevertheless, the mechanisms of decline platelet count alongside thyroid disease have not been extensively investigated. Clinical Case A case reported 55-year-old man who has receiving continuous treatment methimazole for 7 years. The physical examination revealed asthenic man, enlarged gland, inactive bilateral orbitopathy and multiple...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Background: Hypothyroidism is the deficiency in production of thyroid hormones to meet requirements peripheral tissues. Subclinical hypothyroidism (SCH) defined biochemically as normal serum free thyroxin concentration presence an elevated thyroid-stimulating hormone (TSH) concentration. SCH may be associated with low-grade systemic inflammation (increased high sensitivity-C reactive protein (hs-CRP), one possible explanation that TSH adipocytes promotes release interleukin-6 (IL-6). Studies...